Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 6/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 6/20 | 0.56 |
| ▸ | TACR1 | P25103 | 2/20 | 0.55 |
| ▸ | CTSL | P07711 | 1/20 | 0.54 |
| ▸ | CTSB | P07858 | 1/20 | 0.54 |
| ▸ | CTSS | P25774 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 1/20 | 0.54 |
| ▸ | TYR | P14679 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.53 |
| ▸ | MME | P08473 | 1/20 | 0.52 |
| ▸ | ECE1 | P42892 | 1/20 | 0.52 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25182267 | 0.92 | ITGB3 (0.51) | ITGB3ITGA2BTACR1CTSLCTSB | |
| SCHEMBL7480565 | 0.91 | GPR34 (0.56) | ITGB3ITGA2BTACR1CTSLCTSB | |
| SCHEMBL29972959 | 0.91 | GPR34 (0.56) | ITGB3ITGA2BTACR1CTSLCTSB | |
| SCHEMBL13391981 | 0.90 | ALDH1A1 (0.60) | TACR1CTSLCTSBCTSSCTSK | |
| SCHEMBL5929949 | 0.90 | ALDH1A1 (0.60) | TACR1CTSLCTSBCTSSCTSK | |
| SCHEMBL8258487 | 0.88 | GPR34 (0.63) | ITGB3ITGA2BTACR1CTSLCTSB | |
| SCHEMBL2511842 | 0.88 | GPR34 (0.63) | ITGB3ITGA2BTACR1CTSLCTSB | |
| SCHEMBL7291131 | 0.88 | GPR34 (0.63) | ITGB3ITGA2BTACR1CTSLCTSB | |
| SCHEMBL10722503 | 0.88 | GPR34 (0.63) | ITGB3ITGA2BTACR1CTSLCTSB | |
| SCHEMBL219151 | 0.87 | TACR1 (0.68) | ITGB3ITGA2BTACR1CTSLCTSB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100099898-A1 | Processes and Intermediates For Preparing Benzyle Epoxides | ELAN PHARMACEUTICALS, INC. | 2010-04-22 | — | — | US | claimed |
| US-7638646-B2 | Processes and intermediates for preparing benzyl epoxides | ELAN PHARMACEUTICALS INC. (US) | 2009-12-29 | — | — | US | claimed |
| US-20050130936-A1 | Processes and intermediates for preparing benzyl epoxides | PHARMACIA & UPJOHN COMPANY | 2005-06-16 | — | — | US | claimed |
| US-20030004360-A1 | Processes and intermediates for preparing benzyl epoxides | PHARMACIA & UPJOHN COMPANY | 2003-01-02 | — | — | US | claimed |
| WO-2025238360-A1 | NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF | CENTAURI THERAPEUTICS LIMITED (GB) | 2025-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100099898-A1 | Processes and Intermediates For Preparing Benzyle Epoxides | VKORC1, EPOR, POR | ITGB3 1947/4885ITGA2B 1364/4885TACR1 2238/4885 |
| US-20050130936-A1 | Processes and intermediates for preparing benzyl epoxides | CYP2F1, VKORC1, POR | ITGB3 1893/4885ITGA2B 1203/4885TACR1 2390/4885 |
| US-20030004360-A1 | Processes and intermediates for preparing benzyl epoxides | CYP2F1, VKORC1, VKORC1L1 | ITGB3 1768/4885ITGA2B 1226/4885TACR1 2282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.